Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 10 studies | 40% ± 26% | |
| adipocyte | 9 studies | 36% ± 8% | |
| oligodendrocyte precursor cell | 8 studies | 29% ± 13% | |
| fibroblast | 5 studies | 27% ± 10% | |
| GABAergic neuron | 5 studies | 56% ± 20% | |
| endothelial cell | 4 studies | 26% ± 12% | |
| GABAergic interneuron | 3 studies | 33% ± 4% | |
| interneuron | 3 studies | 52% ± 14% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 9 studies | 33% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 1060.05 | 652 / 653 | 82% | 4.62 | 494 / 605 |
| brain | 89% | 767.89 | 2358 / 2642 | 91% | 4.55 | 641 / 705 |
| prostate | 97% | 681.94 | 238 / 245 | 67% | 1.91 | 335 / 502 |
| lung | 99% | 967.95 | 574 / 578 | 62% | 2.81 | 713 / 1155 |
| breast | 100% | 1386.72 | 458 / 459 | 50% | 1.14 | 564 / 1118 |
| adrenal gland | 97% | 363.79 | 250 / 258 | 50% | 1.51 | 114 / 230 |
| esophagus | 96% | 616.10 | 1392 / 1445 | 39% | 1.04 | 72 / 183 |
| ovary | 76% | 313.94 | 137 / 180 | 57% | 1.74 | 244 / 430 |
| skin | 69% | 289.77 | 1257 / 1809 | 63% | 4.50 | 298 / 472 |
| uterus | 99% | 752.91 | 169 / 170 | 23% | 1.30 | 105 / 459 |
| bladder | 100% | 1009.10 | 21 / 21 | 19% | 0.48 | 95 / 504 |
| intestine | 90% | 450.44 | 870 / 966 | 15% | 0.36 | 81 / 527 |
| adipose | 100% | 1947.64 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| stomach | 71% | 450.16 | 256 / 359 | 28% | 0.67 | 81 / 286 |
| blood vessel | 87% | 420.99 | 1156 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 2% | 3.40 | 5 / 328 | 54% | 1.12 | 97 / 178 |
| spleen | 52% | 143.73 | 125 / 241 | 0% | 0 | 0 / 0 |
| liver | 32% | 74.73 | 73 / 226 | 13% | 0.24 | 53 / 406 |
| eye | 0% | 0 | 0 / 0 | 41% | 0.85 | 33 / 80 |
| kidney | 16% | 43.93 | 14 / 89 | 22% | 0.40 | 196 / 901 |
| muscle | 33% | 100.09 | 265 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 27% | 0.40 | 12 / 45 |
| heart | 9% | 23.75 | 81 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.10 | 2 / 29 |
| peripheral blood | 3% | 10.19 | 24 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
| GO_0035023 | Biological process | regulation of Rho protein signal transduction |
| GO_0005829 | Cellular component | cytosol |
| GO_0005096 | Molecular function | GTPase activator activity |
| Gene name | ARHGAP20 |
| Protein name | Rho GTPase-activating protein 20 (Rho-type GTPase-activating protein 20) ARHGAP20 Rho GTPase activating protein 20 |
| Synonyms | KIAA1391 |
| Description | FUNCTION: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. . |
| Accessions | ENST00000533353.5 [Q9P2F6-2] ENST00000527598.1 [Q9P2F6-4] ENST00000524756.5 [Q9P2F6-3] A0A2X0U2C5 A0A0C4DGG5 ENST00000528829.5 [Q9P2F6-4] ENST00000683387.1 [Q9P2F6-1] ENST00000529591.5 Q9P2F6 ENST00000260283.8 [Q9P2F6-1] |
